Prothena Corporation plc (PRTA)

Prothena Corporation plc (PRTA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $435M; returns 1 day -0.6%, 1 week -1.8%, 1 year -15.9%.

Prothena Corporation plc (PRTA) is a clinical-stage biotechnology company focused on developing novel therapies for neurodegenerative and protein misfolding diseases, including AL amyloidosis, Alzheimer's disease, and Parkinson's disease.

Groups PRTA belongs to

• Biotechnology
• Clinical Stage Biotech
• Neuroscience
• Clinical Stage
• Alzheimer's Disease
• Rare Diseases
• Neurological Disorders
• Biopharmaceutical
• Healthcare
• Drug Discovery
• Life Sciences
• Antibody Therapeutics

PRTA financial model: income statement, cash flow and balance sheet